Nu Skin’s research and development partner, LifeGen Technologies, recently received a grant from the National Institutes of Health (NIH) in the United States to identify genes in adipose (fat) tissue that are regulated by a calorie restricted diet.
“We congratulate LifeGen on receiving this prestigious and significant grant from the NIH,” said Joe Chang, Ph.D., Nu Skin chief scientific officer and executive vice president of product development. “Nu Skin is proud to partner with such leaders in genetic and aging science. It is a recognition of LifeGen’s novel approach to aging research and its potential to yield innovative anti-aging products in the future. LifeGen’s research is illuminating genetic mechanisms of aging and how to influence such mechanisms with different ingredients and compounds.”
The award is a Phase I Small Business Innovative Research (SBIR) grant from the United States National Institute on Aging (NIA). The project is similar to previous research by LifeGen that has identified genes in muscle and brain and heart tissues that are regulated by a calorie restricted diet. The technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue.
See the full press release at www.lifegentech.com/news-events.html.
The National Institute on Aging (NIA) is one of 27 Institutes and Centers of the National Institutes of Health (NIH) and leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life. In 1974, the United States Congress granted authority to form NIA to provide leadership in aging research, training, health information dissemination, and other programs relevant to aging and older people. The NIH has a $30 billion budget and extramural grants (grants made to investigators outside of the NIH) account for more than 80 percent of that budget. It is estimated that only 20 percent of the projects submitted for consideration are approved for NIH grants each year.